Related Experiment Video

Updated: Jul 8, 2026

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
10:47

Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice

Published on: April 14, 2011

Adverse reactions to simultaneous influenza and pneumococcal conjugate vaccinations in children: randomized

Angelique G S C Jansen1, Elisabeth A M Sanders, Sara Smulders

  • 1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. A.G.S.C.Jansen@umcutrecht.nl

Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|January 29, 2008
PubMed

Insights

Simultaneous administration of influenza and pneumococcal conjugate vaccines (IV + PV) in children showed slightly increased local and systemic reactions compared to other vaccination schedules. These findings are crucial for future pediatric vaccination strategies.

Area of Science:

  • Pediatrics
  • Immunology
  • Vaccinology

Background:

  • Respiratory tract infections are common in children.
  • Vaccination is a key preventive strategy.
  • Assessing combined vaccine safety is important for adherence.

Purpose of the Study:

  • To evaluate the safety of simultaneous influenza and pneumococcal conjugate vaccination in children.
  • To compare adverse events between combined vaccination and other schedules.

Main Methods:

  • Randomized double-blind controlled trial.
  • 579 children aged 18-72 months were enrolled.
  • Three groups: IV + PV, IV + placebo, Hepatitis B + placebo.

Main Results:

  • No immediate adverse reactions observed.
  • Local reactions resolved within 2 days for most children.
  • Increased prevalence of local (30%) and systemic (10%) reactions in the IV + PV group.

Conclusions:

  • Simultaneous influenza and pneumococcal conjugate vaccination is generally safe in children.
  • A slightly higher incidence of local and systemic reactions warrants consideration.
  • Findings inform optimal pediatric vaccination schedule design.

More Related Videos

Assessing Respiratory Immune Responses to Haemophilus Influenzae06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccinations01:51

Vaccinations

Overview
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...